Taurine for Longevity & Metabolic Health — Supplements
2023 Science study found plasma taurine declines 80% with aging across 60+ species; supplementation extended mouse lifespan 10-12% and reversed multi-organ hallmarks of aging.
Overview
Taurine (2-aminoethanesulfonic acid) is a conditionally essential sulfonic amino acid — not used in protein synthesis — found at high concentrations in the brain, heart, retina, and skeletal muscle. A landmark 2023 study published in Science (Singh et al., Columbia University, n=14,000+ humans, plus mouse and non-human primate experiments) established taurine as a potential longevity molecule. The study found plasma taurine levels decline 80% between youth and old age across 60+ species from worms to humans — a phylogenetically conserved aging signature. Taurine supplementation (1,000 mg/kg/day in mice) extended median lifespan by 10–12% in male and female mice beginning at middle age. Supplemented animals showed reversal of hallmarks of aging across multiple organs: increased muscle strength and endurance, reduced bone loss, improved neurogenesis, reduced anxiety and depression-like behaviors, improved insulin sensitivity, and reduced systemic inflammation. In non-human primates (cynomolgus monkeys), taurine supplementation reduced body weight, bone loss, liver enzyme elevations, and markers of immune senescence. In a prospective human cohort study nested within the same publication, higher serum taurine levels were associated with lower rates of type 2 diabetes, cardiovascular disease, hypertension, obesity, and inflammation markers — a dose-dependent correlation independent of confounders. Human interventional RCTs specifically investigating taurine for longevity endpoints are underway but not yet published; the mechanistic and multi-species evidence is unprecedented in strength.
Indications
- Longevity and healthy aging (primary evidence-based indication)
- Exercise performance and muscle recovery
- Cardiovascular health (blood pressure, cardiac function)
- Metabolic health — insulin sensitivity, glycemic control
- Neurological health — anxiety, depression, neurogenesis
- Eye health (retinal taurine depletion associated with degeneration)
Mechanism of Action
Taurine is incorporated into mitochondrial tRNA as taurine-modified wobble uridine — essential for correct translation of mitochondrially-encoded respiratory chain subunits (ND1, ND5, COX2). Age-related taurine decline impairs this modification, causing mitochondrial dysfunction (electron chain mistranslation), reduced ATP production, and increased ROS
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Taurine | 500–2,000 mg | Once to twice daily | Most human studies use 1,000–3,000 mg/day; start at 500 mg and increase; the 2023 Science study used high doses in animals — human equivalent estimated at 3–6 g/day for 70 kg adult |
Evidence Grade
GRADE B
Safety & Contraindications
- Excellent safety profile — taurine is GRAS; widely used in energy drinks at 1,000 mg/serving without significant adverse effects
- No significant drug interactions identified at typical supplemental doses (500–3,000 mg/day)
- Highly bioavailable — well-absorbed orally; not significantly degraded by gut bacteria
- No reported toxicity in humans up to 6,000 mg/day in clinical studies
- Produced endogenously from cysteine and methionine — supplemental taurine does not suppress endogenous synthesis
- May have mild blood pressure-lowering effects — monitor in hypotensive patients
- Vegetarians and vegans have lower baseline plasma taurine (no dietary animal-source taurine) — supplementation especially beneficial in this population